FDA Clearance Tracker · P830055-S311
LCS® Total Knee System
Last checked: Nov 20, 2026Latest source record: Feb 27, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Feb 27, 2024
Approved
Time to decision
207 days
Received Aug 4, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P830055-S311
- Device name
- LCS® Total Knee System
- Applicant
- Depuy, Inc.
- Applicant location
- Warsaw, IN
- Received
- Aug 4, 2023
- Decided
- Feb 27, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P830055
Device type
- Device type
- Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing (NJL)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
for partial manufacture of Attune Cemented Cruciate Retaining (CR) and Posterior Stabilized (PS) femoral components at an additional manufacturing facility located at Croom Precision Tooling LTD, SFADCO Enterprise Centre, Croom, Limerick, Ireland.
Source documents
Other decisions for Depuy, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.